FACTORS RELATED TO POOR OUTCOMES IN ST - SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) PATIENTS RECEIVING TIMELY VERSUS DELAYED THERAPY

Main Article Content

Muhammad Hashim kalwar
Sarfraz Hussain Sahito
Mahwish Abbas
Ravi Raja
Jaghat Ram
Ghulam Abbas Shaikh

Keywords

ST-segment elevation myocardial infarction, adults, diabetes, hypertension, smoking

Abstract

Background: Coronary artery disease is the leading cause of death worldwide. Quick diagnosis and treatment are critical for improving outcomes in acute coronary syndrome. In cases of ST-segment elevation myocardial infarction (STEMI), prompt reperfusion is crucial since it shortens the overall length of tissue ischemia. A 30-minute delay in reperfusion can lower life expectancy by approximately one year. Despite huge attempts to assure timely treatment for STEMI over the last few decades, one-third of STEMI patients still do not receive reperfusion therapy on time.


Objective: To determine factors related to poor outcomes in STEMI patients receiving timely versus delayed therapy.


Study design: A comparative study


Place and Duration: This study was conducted in National Institutes of Cardiovascular Diseases Sukkur from February 2023 to February 2024


Methodology: It is assumed that severe adverse cardiac events occur in 22.9% of patients with early therapy (group A) and 42.9% of patients with delayed treatment (group B). About 200 patients were selected according to the selection criteria. All adult patients suspected of having a myocardial infarction (MI) underwent screening. To be eligible for the study, participants had to be between the ages of 18 and 65 years, male or female, and have a STEMI diagnosis.


Results: There were a total of 200 patients enrolled in this research. All of them were divided into 2 groups equally; Group A and Group B. There were 100 patients in each group. There were a total of 150 men and 50 women enrolled in this study. Of the total cases, 95 (47.5%) had diabetes, 60 (30.0%) smoked, and 91 (45.5%) were hypertensive. In group A worst socioeconomic status was present in  20% of cases, 50% cases were from rural areas, 9% had delayed response in emergency room, while 12% cases had history of chronic stable angina. Furthermore in group B worst socioeconomic status was present in 65% of cases, 47% cases were from rural areas, 20% had delayed response in emergency room, while 33% cases had history of chronic stable angina.


Conclusion: STEMI delays in presentation and treatment are frequently attributed to measurable reasons. This leads to lengthier hospital stays and a higher risk of in-hospital complications such re-infarction, acute heart failure, ventricular fibrillation, and mortality.

Abstract 68 | pdf Downloads 31

References

1. Ashraf S, Farooq U, Shahbaz A, Khalique F, Ashraf M, Akmal R, Siddle MT, Ashraf M, Ashraf S, Ashraf S, Ghufran M. Factors Responsible for Worse Outcomes in STEMI Patients With Early vs Delayed Treatment Presenting in a Tertiary Care Center in a Third World Country. Current Problems in Cardiology. 2023 Sep 2:102049.
2. Ashraf S, Masood S, Shahbaz A, Saboor QA. Factors Responsible for Worse Outcomes in Stemi Patients with Early vs Delayed Treatment Presenting in a Tertiary Care Center. Pakistan Heart Journal. 2023 Nov 16;56(Supplement_2):S11-.
3. He J, Bellenger NG, Ludman AJ, Shore AC, Strain WD. Treatment of myocardial ischemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope. Rev Cardiovasc Med 2022;23:23. https:// doi.org/10.31083/j.rcm2301023.
4. Poorhosseini H, Saadat M, Salarifar M, Mortazavi SH, Geraiely B. Pre-hospital delay and its contributing factors in patients with ST-elevation myocardial infarction; a cross sectional study. Arch Acad Emerg Med 2019;7:1–8.
5. Lim SC, Rahman A, Yaacob NM. Pre-hospital factors influencing time of arrival at emergency departments for patients with acute ST-elevation myocardial infarction. Malays J Med Sci 2019;26:87–98.
6. Tongpeth J, Du HY, Clark RA. Development and feasibility testing of an avatar-based education application for patients with acute coronary syndrome. J Clin Nurs 2018;27:3561–71.
7. Hsia RY, Krumholz H, Shen YC. Evaluation of STEMI regionalization on access, treatment, and outcomes among adults living in nonminority and minority communities. JAMA Netw Open 2020;3. E2025874-e.
8. Kritikou I, Chalkias A, Koutsovasilis A, Xanthos T. Characteristics and survival to discharge of patients with STEMI between a PPCI-capable hospital and a non-PPCI hospital: A prospective observational study. Acute Cardiac Care. 2014 Dec 1;16(4):118-22.
9. Yiadom MY, Baugh CW, Jenkins CA, Tanski M, Mumma BE, Vogus TJ, Miller KF, Jackson BE, Lehmann CU, Dorner SC, West JL. Outcome Differences Associated with STEMI Diagnostic Delay: Disparities on the Frontlines of STEMI Care. Circulation: Cardiovascular Quality and Outcomes. 2018 Apr;11(suppl_1):A185-.
10. Noorani F, Runge M, Tripathi S, Patil D, Lanjewar C, Eagle K, Kerkar P. Pre-Hospital Delays in Care for STEMI Patients in Mumbai: Challenges and Opportunities. Circulation. 2016 Nov 11;134(suppl_1):A14400-.
11. Feng L, Li M, Xie W, Zhang A, Lei L, Li X, Gao R, Wu Y. Prehospital and in-hospital delays to care and associated factors in patients with STEMI: an observational study in 101 non-PCI hospitals in China. BMJ open. 2019 Nov 1;9(11):e031918.
12. Roberto M, Radovanovic D, de Benedetti E, Biasco L, Halasz G, Quagliana A, Erne P, Rickli H, Pedrazzini G, Moccetti M. Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017. Revista Española de Cardiología (English Edition). 2020 Sep 1;73(9):741-8.
13. Khaled MFI, Banerjee SK, Adhikary DK, et al. Factors influencing pre-hospital delay in patients with acute myocardial infarction. Uni Heart J 2019;15:79–85.
14. Rivero F, Bastante T, Cuesta J, et al. Factors associated with delays in seeking medical attention in patients with ST-segment elevation acute coronary syndrome. Rev Esp Cardiol 2016;69:279–85.
15. Alex AG, Lahiri A, Devika GT, George OK. Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care center in India. J Postgrad Med 2018;64:80–5.
16. Beig JR, Tramboo NA, Kumar K, et al. Components and determinants of therapeutic delay in patients with acute ST-elevation myocardial infarction: a tertiary care hospital-based study. J Saudi Heart Assoc 2017;29:7–14.
17. Sharma YP, Krishnappa D, Kanabar K, et al. Clinical characteristics and outcome in patients with a delayed presentation after ST-elevation myocardial infarction and complicated by cardiogenic shock. Indian Heart J 2019;71:387–93.
18. Janssens GN, van der Hoeven NW, Lemkes JS, et al. 1-year outcomes of delayed versus immediate intervention in patients with transient ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2019;12:2272–82.
19. Wu J-W, Hu H, Li D, Ma L-K. In-hospital outcomes of delayed stenting in hemodynamically stable patients with ST-segment elevation myocardial infarction: the CCC (Care for Cardiovascular Disease in China) project. Cardiovasc Diagn Ther 2019;9:462.
20. Shahin M, Obeid S, Hamed L, et al. Occurrence and impact of time delay to primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Cardiol Res 2017;8:190.